The IC50 was calculated for each of the cell lines from the data presented in Figure 1 and is shown in micromoles
| Line . | IC50, μM . |
|---|---|
| Human pre T-LBL cell lines | |
| KOP-TK1 | 0.83 |
| MOLT16 | 0.83 |
| ALL-SIL | 2.78 |
| HPB-ALL | 3.89 |
| TALL-1 | 4.17 |
| HSB2 | 7.78 |
| Jurkat | 8.89 |
| CEM | 15.0 |
| DU528 | 15.0 |
| SUPT11 | 27.5 |
| Human non-T leukemic cell lines | |
| MV4-11 | 3.89 |
| Nalm6 | 9.17 |
| Kasumi1 | 12.8 |
| HEL | 16.9 |
| U937 | 21.4 |
| NB4 | 22.2 |
| HL60 | 24.4 |
| THP1 | 28.1 |
| K562 | 39.7 |
| Murine leukemic cell lines | |
| 12/1 | 3.06 |
| 6645/4 | 3.38 |
| 6605/4 | 3.61 |
| 6812/2 | 6.67 |
| St4113 | 6.67 |
| F4-6 | 14.4 |
| Line . | IC50, μM . |
|---|---|
| Human pre T-LBL cell lines | |
| KOP-TK1 | 0.83 |
| MOLT16 | 0.83 |
| ALL-SIL | 2.78 |
| HPB-ALL | 3.89 |
| TALL-1 | 4.17 |
| HSB2 | 7.78 |
| Jurkat | 8.89 |
| CEM | 15.0 |
| DU528 | 15.0 |
| SUPT11 | 27.5 |
| Human non-T leukemic cell lines | |
| MV4-11 | 3.89 |
| Nalm6 | 9.17 |
| Kasumi1 | 12.8 |
| HEL | 16.9 |
| U937 | 21.4 |
| NB4 | 22.2 |
| HL60 | 24.4 |
| THP1 | 28.1 |
| K562 | 39.7 |
| Murine leukemic cell lines | |
| 12/1 | 3.06 |
| 6645/4 | 3.38 |
| 6605/4 | 3.61 |
| 6812/2 | 6.67 |
| St4113 | 6.67 |
| F4-6 | 14.4 |
IC50 indicates 50% inhibitory concentration; and pre-T-LBL, precursor T-cell lymphoblastic leukemia/lymphoma.